Table 1. Baseline characteristics of 77 patients (pts) with metastatic prostate cancer.

Characteristic	Number (% or interquartile range)
Age, years	70 (63–77)
PSA at diagnosis, ng/mL	21.1 (7.7–95.1)
Initial treatment:
Radical prostatectomy	24 (31%)
Radiation therapy to the prostate	16 (21%)
No treatment	37 (48%)
Sites of metastasis:
Bone only	25 (33%)
Lymph node and bone	31 (40%)
Lymph node only	6 (8%)
Visceral disease	14 (18%)
Bone and soft tissue (other than lymph node)	1 (1%)
CTC counts/7.5 mL blood – median (IQR)	29 (7–89)
PSA, ng/mL – median (IQR)	188.2 (65.9–573.4)

FISH probe	Number of pts samples hybridized	Number (%) of pts with FISH results
AR only	13	13 (100%)
AR + MYC	15	11 (73%)
MYC + 8p	23	18 (78%)
AR + MYC + 8p	26	25 (96%)
Total	77	67 (87%)